Activity OverviewThis Global Journal Club webinar is part of the Global Webinar Series created for a global audience of rheumatologists and rheumatology health professionals. This session, recorded on September 17, 2025, facilitated a discussion of two recent and impactful articles published in Arthritis & Rheumatology with the authors:Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid ArthritisJoshua F. Baker MD, MSCorporal Michael J. Crescenz Department of Veterans Affairs Medical Center and the University of Pennsylvania, PhiladelphiaEfficacy and Safety of Sodium–Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events, and Safety Outcomes in Patients With Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population-Based Target Trial EmulationKaren H. Costenbader MD, MPHDivision of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MassachusettsGlobal Meet the Experts Webinar SeriesThis activity is part of a series. See the other activities in the series below.Global Journal Club Webinar: April 2025Global Journal Club Webinar: September 2025Global Meet the Experts Webinar Series: Auto-inflammatory DiseasesGlobal Meet The Experts Webinar Series: Interstitial Lung DiseaseGlobal Meet The Experts Webinar Series: Lupus NephritisGlobal Meet the Experts Webinar Series: MyositisGlobal Meet The Experts Webinar Series: Rheumatoid ArthritisRegistration is complimentary for ACR/ARP members. If you are not a member, consider joining ACR/ARP.Target AudienceRheumatologists, rheumatology interprofessionals, researchers, educators, fellows in training, health services researchers, and primary care providers.Learning ObjectivesUpon completion of this activity, participants should be able to:Develop the ability to critically analyze and evaluate recent research articles in the field of rheumatology, identifying key findings, methodologies, and implications for clinical practiceHave enhanced knowledge and insights into emerging trends, technologies, and advancements in global rheumatologyCE & MOC InformationThis activity is not eligible for CME/MOC.Acknowledgement of Commercial SupportNo commercial support was provided for this activity.Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.

Activity OverviewThe Global Meet the Experts webinar is part of an ongoing virtual educational series for a global health audience of rheumatologists and rheumatology professionals. This session includes three case presentations of rheumatoid arthritis from around the world, with a focus on the challenging aspects of diagnosis and/or management. The cases were selected after a call inviting submissions from across the globe. The webinar features an engaging panel discussion between three leading international authorities in the field.Expert PanelSharon Dowell, MD, Howard University Hospital, Washington DC, USADennis McGonagle, FRCPI, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, UKGlobal Meet the Experts Webinar SeriesThis activity is part of a series. See the other activities in the series below.Global Meet the Experts Webinar Series: Auto-inflammatory DiseasesGlobal Meet The Experts Webinar Series: Interstitial Lung DiseaseGlobal Meet the Experts Webinar Series: Lupus NephritisGlobal Meet The Experts Webinar Series: MyositisGlobal Journal Club Webinar - April 2025Registration is complimentary for ACR/ARP members. If you are not a member, consider joining ACR/ARP.Target AudienceRheumatologists, rheumatology interprofessionals, educators, health educators, primary care providers who care for patients with rheumatic disease, fellows-in-training, and residents.Learning ObjectivesUpon completion of this activity, participants should be able to:Have increased knowledge of diagnostic and management approaches used by experts for challenging casesRecognize innovative care opportunities for patients with rheumatoid arthritis, in different health systems internationallyHave increased confidence to initiate patient-oriented diagnosis and treatment for people with rheumatoid arthritisCE & MOC InformationThis activity is not eligible for CME/MOC.Acknowledgement of Commercial SupportNo commercial support was provided for this activity.Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.

Activity OverviewThe ACR Convergence Replay includes six popular video lectures from scientific sessions at ACR Convergence 2024, plus a Q&A session for each. The lectures encompass a variety of topics, including systemic sclerosis, rheumatoid arthritis-related interstitial lung disease, juvenile dermatomyositis, and the use of AI documentation in rheumatology. The activity includes the following sessions: Optimizing the Management of Skin Disease in Systemic Sclerosis: Using Clinical Features and Novel Disease Activity Measures to Guide Treatment DecisionsAre We Putting the CAR-T Before the Horse?Rheumatoid Arthritis-Associated Interstitial Lung Disease: Advances in Screening, Diagnosis and Patient PhenotypingAI: The Next Breakthrough in Documentation for RheumatologyAnti-MDA5 Juvenile Dermatomyositis: Clinical Presentation and TreatmentYear in Review Registration is discounted for ACR/ARP members. If you are not a member, consider joining ACR/ARP. ACR/ARP Member: $299 ACR/ARP Potential Member: $399Target AudienceRheumatologists, internists, primary care providers, physician assistants, residents, fellows in training, advanced practice nurses, students, rheumatology interprofessionals who care for patients with rheumatic diseases, and those interested or engaged in rheumatology research.Learning ObjectivesUpon completion of this activity, participants should be able to: Analyze and explain recent scientific and clinical advancements in understanding the pathogenesis of rheumatic diseases Evaluate and demonstrate proficiency in diagnosing and managing a range of rheumatic diseases and conditions Apply evidence-based strategies to effectively manage emerging challenges in rheumatic conditionsCE/MOC InformationCMEACCME Accreditation StatementThe American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AMA Designation Statement The American College of Rheumatology designates this Enduring Material for a maximum of 8.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Participants can claim up to 1.25 AMA PRA Category 1 Credit(s)™ for completing the pre-and post-assessments, and up to 7.25 AMA PRA Category 1 Credit(s)™ for attending the ACR Convergence Replay 2024. CME credit must be claimed by April 3, 2028, at 11:59 PM ET.Financial Relationship DisclosuresACR Disclosure StatementIt is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity. Nature of Financial Relationships All individuals that participate in this activity and were able to change or influence the content of the activity have disclosed to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to: Advisor or review panel memberConsultantEmployeeOfficer or Board MemberGrant/research supportSpeaker/honoraria includes speaker’s bureau, symposia, and expert witnessIndependent contractorExecutive role and/or ownership interestRoyalties and/or patent beneficiaryIntellectual property/patentsStock options or bond holdings in a for-profit corporation or self-directed pension planPrivate investigatorExpert witnessEquity interestOther: specify details None: Has no relevant financial relationship(s) with ineligible companies to disclose. All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated. ACR Convergence Replay 2024 Financial Relationship DisclosuresAcknowledgment of Commercial Support  No commercial support was provided for this activity. Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.

Activity OverviewThe Rheumatology Review Course features key updates covering a wide range of rheumatology diseases. The activity contains eight lectures recorded at ACR Convergence 2024. Each session is approximately 45 minutes and includes a Q&A session.  The Review Course lectures include: To Be or Not to Behcet’s? Differentials for Oral UlcersPsoriatic Arthritis Management ReviewGeriatric Concerns in RheumatologyUpdates in SarcoidosisPain Management for the RheumatologistBeyond the Surface: Management of Calcinosis in Connective Tissue DiseasesCase-Based Approach to Metabolic Bone DiseaseChallenging Cases in Rheumatoid Arthritis Registration is discounted for ACR/ARP members. If you are not a member, consider joining the ACR/ARP.ACR/ARP Member: $399ACR/ARP Potential Member: $599 Target AudienceRheumatologists, physicians, primary care providers, fellows in training, physician assistants, advanced practice nurses, nurses, occupational therapists, physical therapists, pharmacists, residents, rheumatology interprofessionals, professionals interested in or engaged in rheumatology research.Learning ObjectivesUpon completion of this activity, participants should be able to:Apply the concept of complex aphthosisIdentify active disease in each PsA domainDescribe the unique aspects and considerations when caring for older adults with rheumatic diseasesRecognize areas of practice vulnerability to disparity, racism, and biasIdentify what calcinosis is in connective tissue diseasesIdentify presentation, work-up, and treatment for hypophosphatasiaDiscuss recent data informing therapeutic options available in an MTX-IR patientImplement strategies to address multi-morbidity in management of RA and D2T RACE & MOC InformationCMEACCME Accreditation StatementThe American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  See the ACR's CME Mission Statement. For more information, download the AMA PRA Booklet.   AMA Designation Statement The American College of Rheumatology designates this Enduring Material for a maximum of 7.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.CME credit must be claimed by December 18, 2027, at 11:59 PM ET. MOCMOC Recognition Statement: American Board of Internal Medicine (ABIM)Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.  After submitting a reflective statement with key takeaways from the activity, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal. MOC points must be claimed by December 18, 2027, at 11:59 PM ET. Financial Relationship DisclosuresACR Disclosure StatementIt is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.Nature of Financial RelationshipsAll individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:Advisor or review panel memberConsultantEmployeeOfficer or Board MemberGrant/research supportSpeaker/honoraria includes speaker’s bureau, symposia, and expert witnessIndependent contractorExecutive role and/or ownership interestRoyalties and/or patent beneficiaryIntellectual property/patentsStock options or bond holdings in a for-profit corporation or self-directed pension planPrivate investigatorExpert witnessEquity interestOther: specify details  None: Has no relevant financial relationship(s) with ineligible companies to disclose.All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated. Planning/Faculty Team MembersThe following planning / faculty team members have the following financial relationships with ineligible companies to disclose.Johannes Nowatzky, MD - Soligenix: Advisor or Review Panel Member (Ongoing)Ana-Maria Orbai, MD, MHS - AbbVie/Abbott: Grant/Research Support (Ongoing); Amgen: Grant/Research Support (Ongoing); Janssen: Grant/Research Support (Ongoing); UCB: Grant/Research Support (Ongoing)Namrata Singh, MD,MSc – Mustang Bio; ConsultantJulie Paik, MD, MHS - Alexion: Grant/Research Support (Ongoing); ArgenX: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Guidepoint: Consultant (Ongoing); Priovant: Grant/Research Support (Ongoing)Lesley Ann Saketkoo, MD, MPH - Kyverna: Grant/Research Support (Ongoing); Mallinckrodt: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing)Daniel Clauw, MD - Tonix: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Pfizer, Lilly; Lundbeck; Virios; Swing; Neurometrix; Consultant (Ongoing)Antonia Valenzuela, MD, MS – Board Member: SCTC (Secretary), Grant/Research Support: SCTC/PANLARLaura Carbone, MD, MS – Grant funded research; NIH/NIA, R01AG079118, Calculator for Length of Use of Bisphosphonates (CLUB); Department of Defense (DOD), SCI200001, Development of Novel Soluble Epoxide Hydrolase Inhibitotor as a Strategy for Treating Neuropathic Pain in Patients with Spinal Cord Injury; Off-label medication with supporting evidence will be discussed.Iain McInnes, PhD, FRCP - AbbVie: Consultant (Ongoing); Amgen: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Bristol Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); Cabaletta: Consultant (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Causeway Therapeutics: Consultant (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Compugen: Consultant (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Dextera: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Eli Lilly: Consultant (Ongoing), Grant/Research Support (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Moonlake: Consultant (Ongoing); NHS GGC: Officer or Board Member (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing); Sanofi: Consultant (Ongoing); UCB: Consultant (Ongoing), Grant/Research Support (Ongoing); Versus Arthritis: Trustee Status (Ongoing)Review Team MembersThe following review team members have no relevant financial relationship(s) with ineligible companies to disclose. Adena Batterman, LCSW, MSWRebecca Manno, MD, MPHCarlos Ferreira, MAPlanning Team Members The following planning team members have no relevant financial relationship(s) with ineligible companies to disclose.Kai Sun, MD, MS, RhMSUSMyria Stanley, MS, DESSharon RossPriyanjali Pulipati, MBBSNoelle Rolle, MBBS, FACP, FACRAcknowledgement of Commercial SupportNo commercial support was provided for this activity.Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.

Activity OverviewRheum2Learn 2.0 is case-based fundamental clinical rheumatology education for residents. Each interactive activity includes three patient cases that focus on the care and assessment of individuals with rheumatologic diseases. The included activities use interactive patient cases to simulate clinical scenarios commonly encountered in primary care, inpatient, and critical care settings. Learners are guided to recognize disease patterns, build differential diagnoses, select appropriate tests, and develop treatment strategies in collaboration with rheumatology specialists. Key topics span rheumatoid arthritis, lupus, crystalline arthritis, osteoarthritis, myopathies, systemic sclerosis, pediatric rheumatology, infectious arthritis, osteoporosis, and vasculitis. See below for a complete list of the 15 included activities.Rheum2Learn SeriesThis activity is part of a series. See the other activities in the series below.Rheum2Learn 2.0: Crystalline ArthritisRheum2Learn 2.0: Infectious ArthritisRheum2Learn 2.0: Inflammatory MyopathiesRheum2Learn 2.0: Musculoskeletal DisordersRheum2Learn 2.0: Musculoskeletal ExaminationRheum2Learn 2.0: OsteoporosisRheum2Learn 2.0: OsteoarthritisRheum2Learn 2.0: Pediatric RheumatologyRheum2Learn 2.0: Rheumatic Manifestations of Systemic DiseaseRheum2Learn 2.0: Rheumatoid ArthritisRheum2Learn 2.0: Sjögren’s DiseaseRheum2Learn 2.0: SpondyloarthritisRheum2Learn 2.0: Systemic Lupus ErythematosusRheum2Learn 2.0: Systemic SclerosisRheum2Learn 2.0: Systemic VasculitisRegistration is complimentary.Target AudienceResidents in training who may provide care for patients with rheumatic diagnoses in primary care, inpatient, critical care, and other clinical contexts.The activity may also be of interest to medical students, fellows in training, advanced practice providers, practicing physicians, and other health care professionals who seek to strengthen their clinical knowledge of rheumatic diseases.Learning ObjectivesUpon completion of this activity, participants should be able to:Recognize disease patterns using clinical data and patient history.Formulate a comprehensive differential diagnosis based on disease patterns and diagnostic clues.Select appropriate diagnostic tests and labs to narrow down the diagnosis.Develop treatment strategies in collaboration with rheumatology specialists.See individual activities (linked above) for activity-specific learning objectives. CE & MOC InformationThis activity is not eligible for CME/MOC.Acknowledgement of Commercial SupportRheum2Learn 2.0: Inflammatory Myopathies, Rheum2Learn 2.0: Systemic Lupus Erythematosus, Rheum2Learn 2.0: Pediatric Rheumatology, Rheum2Learn 2.0: Rheumatic Manifestations of Systemic Disease, Rheum2Learn 2.0: Sjögren’s DiseaseThese projects were supported by grant number 1 NU58DP006908-01-00 – Component A: Developing and Disseminating Programs to Build Sustainable Lupus Awareness, Knowledge, Skills and Partnerships. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Health and Human Services, Centers for Disease Control and Prevention.Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.

Activity OverviewRheum2Learn 2.0 is case-based fundamental clinical rheumatology education for residents. Each interactive activity includes three patient cases that focus on the care and assessment of individuals with rheumatologic diseases.In this activity, learn more about rheumatoid arthritis (RA), the most common type of inflammatory arthritis.  Practice identifying clinical manifestations, interpreting test results, and developing a differential diagnosis and treatment plan for patients with rheumatoid arthritis.Rheum2Learn SeriesThis activity is part of a series. See all activities in the series below.Rheum2Learn 2.0: Crystalline ArthritisRheum2Learn 2.0: Infectious ArthritisRheum2Learn 2.0: Inflammatory MyopathiesRheum2Learn 2.0: Musculoskeletal DisordersRheum2Learn 2.0: Musculoskeletal ExaminationRheum2Learn 2.0: OsteoporosisRheum2Learn 2.0: OsteoarthritisRheum2Learn 2.0: Pediatric RheumatologyRheum2Learn 2.0: Rheumatic Manifestations of Systemic DiseaseRheum2Learn 2.0: Rheumatoid ArthritisRheum2Learn 2.0: SpondyloarthritisRheum2Learn 2.0: Sjögren’s DiseaseRheum2Learn 2.0: Systemic Lupus ErythematosusRheum2Learn 2.0: Systemic SclerosisRheum2Learn 2.0: Systemic VasculitisRegistration is complimentary.Target AudienceResidents in training who may provide care for patients with rheumatic diagnoses in primary care, inpatient, critical care, and other clinical contexts.The activity may also be of interest to medical students, fellows in training, advanced practice providers, practicing physicians, and other health care professionals who seek to strengthen their clinical knowledge of rheumatic diseases.Learning ObjectivesUpon completion of this activity, participants should be able to:Recognize the typical presentation of rheumatoid arthritisReview the epidemiology, socioeconomic impact, and prognosis of rheumatoid arthritisRecognize the common MSK exam findings of inflammatory/rheumatoid arthritisUnderstand the initial work-up needed to diagnose rheumatoid arthritisRecognize potential pulmonary involvement of rheumatoid arthritis and determine the appropriate work-up and need for high clinical suspicionIdentify differential diagnosis in a patient with rheumatoid arthritis and pulmonary symptomsIdentify the radiographic findings of rheumatoid arthritis and osteoarthritisUnderstand infection risk in patients with rheumatoid arthritis and identify appropriate vaccinations Recognize the increase in cardiovascular risk in patients with rheumatoid arthritis and demonstrate how to incorporate rheumatoid arthritis into cardiovascular risk-factor managementIdentify medications for rheumatoid arthritis that should be avoided during pregnancyCE & MOC InformationThis activity is not eligible for CME/MOC.Acknowledgement of Commercial SupportNo commercial support was provided for this activity.Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.

Activity OverviewThe Fundamentals of Rheumatology Course is a series of 10 activities that provide foundational knowledge and help develop skills that professionals new to rheumatology need to succeed in clinical practice. This activity covers the signs, symptoms, and treatments of rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and spondyloarthropathies in adults and juvenile idiopathic arthritis, (JIA), systemic lupus erythematosus (SLE), and juvenile dermatomyositis (JDM) in children. It addresses key areas such as pain management, psychosocial challenges, rehabilitation, and self-management support strategies.Fundamentals of Rheumatology CourseThis activity is part of a series. See the other activities in the series below.Fundamentals of Rheumatology Course - All ActivitiesActivity 1 –  Discover the Basics: Immunology, Autoimmunity, and InflammationActivity 2 – Explore Systemic Inflammatory Diseases in Adults and ChildrenActivity 3 –  Differentiate Non-Inflammatory Conditions: Osteoarthritis, Fibromyalgia, and Soft Tissue DisordersActivity 4 –  Assess your Patient with Rheumatic DiseaseActivity 5 –  Address Psychosocial Impact to Enhance Patient OutcomesActivity 6 –  Counsel your Patient on Rheumatology MedicationsActivity 7 –  Help Your Patient Manage Their PainActivity 8 –  Use Rehabilitation to Improve Your Patient’s Function, Fatigue, and PainActivity 9 –  Stimulate and Support Your Patient’s Self-ManagementActivity 10 –  Optimize Care for Your Pediatric PatientRegistration is complimentary for ACR/ARP members. If you are not a member, consider joining ACR/ARP.Target AudienceProfessionals looking to expand their understanding of interdisciplinary rheumatology care: nurses, occupational therapists, office managers and staff, physical therapists, pharmacists, pharmacologists, practice administrators, psychologists, researchers, social workers and community health workers, epidemiologists, health educators, health services researchers, medical assistants, rheumatology interprofessionals, and students.Experienced professionals may also find the activity to be a helpful review.Learning ObjectivesUpon completion of this activity, participants should be able to:Define the three major types of pediatric rheumatic diseases in childhood (JIA, SLE, JDM)Identify the signs and symptoms seen in the three major rheumatic diseases of childhoodDescribe initial treatment goals for the three major rheumatic diseases of childhoodIdentify signs and symptoms and other key information about rheumatoid arthritis, systemic lupus erythematosus, and spondyloarthropathies in adultsExplain the rationale for the use of ancillary studies to diagnose and monitor rheumatic disease activity in adultsDescribe key treatment strategies to manage rheumatic disease in adultsCE & MOC InformationCMEACCME Accreditation StatementThe American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. See the ACR's CME Mission Statement. For more information, download the AMA PRA Booklet.AMA Designation StatementThe American College of Rheumatology designates this Enduring Material for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.CME credit must be claimed by June 24, 2028, at 11:59 PM ET.Financial Relationship DisclosuresACR Disclosure StatementIt is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.  Nature of Financial RelationshipsAll individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:Advisor or review panel memberConsultantEmployeeOfficer or Board MemberGrant/research supportSpeaker/honoraria includes speaker’s bureau, symposia, and expert witnessIndependent contractorExecutive role and/or ownership interestRoyalties and/or patent beneficiaryIntellectual property/patentsStock options or bond holdings in a for-profit corporation or self-directed pension planPrivate investigatorExpert witnessEquity interestOther: specify details None: Has no relevant financial relationship(s) with ineligible companies to disclose. All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated. FRC Relaunch 2025 Financial Relationship Disclosures.Acknowledgement of Commercial SupportNo commercial support was provided for this activity.See industry engagement opportunities and benefits of supporting the ACR.Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.